Top Markets
#1 Black Phoenix Black Phoenix +21,656.31%
#2 Nesa Nesa +771.40%
#3 Kinesis Silver Kinesis Silver +55.36%
#4 QuantixAI QuantixAI +23.71%
#5 EXOD EXOD +22.78%
#6 Cash Cat Cash Cat +22.08%
#7 Pons Pons +21.15%
#8 BNB Attestation Service BNB Attestation Service +19.19%
#9 Derive Derive +15.82%
#10 Zest Protocol Zest Protocol +15.64%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Cypherpunk Technologies Inc. Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc.

CYPH
Clasificación en acciones #19166
Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the... Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the acquisition and development of antibody treatments for cancer. The firm's flagship investigational drug, DKN-01, is a monoclonal antibody designed to suppress Dickkopf-related protein 1 and is currently progressing through multiple clinical trials for various esophagogastric, gynecologic, and colorectal cancers. Additionally, the company is advancing FL-501, another monoclonal antibody that targets the GDF-15 protein, which is presently in preclinical development. Cypherpunk has established an agreement with Adimab, LLC and BeiGene, Ltd., granting it options and licenses to advance and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Founded in 2011, the company operates from Cambridge, Massachusetts, and was formerly known as Leap Therapeutics, Inc. until its renaming in November 2025.
Precio por acción
$1.62
Última sincronización: 2026-08-25
Capitalización bursátil
$172.47M
Cambio (1 día)
-3.57%
Cambio (1 año)
446.74%
País
US
Comercio Cypherpunk Technologies Inc. (CYPH)

Categoría

Healthcare
Historial de rendimiento por dividendo de Cypherpunk Technologies Inc. (CYPH)
Rendimiento por dividendo (TTM) de Cypherpunk Technologies Inc. (símbolo bursátil: CYPH) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Cypherpunk Technologies Inc. (CYPH) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH